Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,939.70 | 378.00 | 5.00% |
CAC 40 | 6,896.91 | 203.51 | -2.87% |
DAX 40 | 19,670.88 | 609.38 | -3.00% |
Dow JONES (US) | 40,608.45 | 62.52 | 0.15% |
FTSE 100 | 7,705.87 | 204.66 | -2.59% |
HKSE | 20,264.49 | 136.81 | 0.68% |
NASDAQ | 17,124.97 | 574.37 | 3.47% |
Nikkei 225 | 34,269.71 | 2,555.68 | 8.06% |
NZX 50 Index | 12,232.46 | 425.91 | 3.61% |
S&P 500 | 5,456.90 | 474.13 | 9.52% |
S&P/ASX 200 | 7,742.40 | 367.40 | 4.98% |
SSE Composite Index | 3,186.81 | 0.00 | 0.00% |